NCT04298853View on ClinicalTrials.gov

Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 30, 2020

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Neonatal Abstinence SyndromeNeonatal Opioid WithdrawalNeonatal Opioid Withdrawal Syndrome
Interventions
DRUG

Morphine PRN

Dose given every 3 hours as-needed for severe NAS, defined by a threshold Finnegan score.

DRUG

Morphine scheduled

Dose given every 3 hours on a scheduled basis and slowly weaned once stabilized.

Trial Locations (1)

46202

Indiana University Health Methodist Hospital, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT04298853 - Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome | Biotech Hunter | Biotech Hunter